The Pharmagellan Guide to Biotech Forecasting and Valuation
Autoren
Parameter
Kategorien
Mehr zum Buch
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Buchkauf
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Sprache
- Erscheinungsdatum
- 2017
Wir benachrichtigen dich per E-Mail.
Lieferung
Zahlungsmethoden
Feedback senden
- Titel
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Sprache
- Englisch
- Autor*innen
- Andrew Matthews, Frank S. David, Seth Robey
- Verlag
- Pharmagellan
- Erscheinungsdatum
- 2017
- Einband
- Paperback
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Kategorie
- Wirtschaft
- Beschreibung
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.